8432 Federal Register / Vol. 89, No. 26 / Wednesday, February 7, 2024 / Notices 

SUPPLEMENTARY INFORMATION: The sole 

source award will allow IPPA to support 

panel physicians and their staff to 

perform health assessment and 

management activities in immigrants 

and refugees bound for the U.S. IPPA 

has established a framework and 

mechanisms to develop and implement 

training opportunities. IPPA has 

demonstrated its ability to coordinate 

and implement education and training 

to improve the immigrant medical 

exam. 

International Panel Physicians 

Association Inc is in a unique position 

to conduct this work, as it is the only 

qualified non-governmental 

organization with the technical and 

administrative capacity to conduct the 

specific set of activities needed to 

support the transfer of information to 

CDC/Division of Global Migration 

Health regarding overseas health 

assessment of U.S.-bound refugee 

populations for T.B. and infectious 

disease prevention and control 

activities. 

Summary of the Award 

Recipient: International Panel 

Physicians Association. 

Purpose of the Award: The purpose of 

this award is to secure the services of 

IPPA to facilitate communication and 

training on the technical instructions 

that govern the pre-departure health 

assessment and treatment of U.S.-bound 

immigrants and refugees. 

Amount of Award: The approximate 

year 1 funding amount will be $100,000 

in Federal Fiscal Year (FFY) 2024 funds, 

with a total estimate of $500,000 for the 

5-year period of performance, subject to 

availability of funds. 

Authority: This program is authorized 

under the Public Health Service Act, 

Sections 307 and 317(k)(1) [42 U.S.C. 

242l and 247b(k)(1)], as amended. 

Period of Performance: September 1, 

2024, through August 31, 2029. 

Dated: January 24, 2024. 

Jamie Legier, 

Acting Director, Office of Grants Services, 

Acting Chief Grants Management Officer, 

Centers for Disease Control and Prevention. 

[FR Doc. 2024–02503 Filed 2–6–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Sole Source 

Cooperative Agreement To Fund 

Namibia Ministry of Health and Social 

Services (MOHSS), Rwanda 

Biomedical Center, South African 

Medical Research Council, South 

African National AIDS Council Trust 

(SANAC), Tanzania Commission for 

AIDS (TACAIDS), President’s Office— 

Regional Administration and Local 

Government (PO–RALG), and Vietnam 

Administration for HIV/AIDS Control 

(VAAC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award(s) of approximately $8,000,000 

for Year 1 funding to MOHSS, 

$4,000,000 for Year 1 funding to 

Rwanda Biomedical Center, $3,000,000 

for Year 1 funding to South African 

Medical Research Council, $3,000,000 

for Year 1 funding to SANAC, $500,000 

for Year 1 funding to TACAIDS, 

$500,000 for Year 1 funding to PO– 

RALG, and $6,000,000 for Year 1 

funding to VAAC. The(se) award(s) will 

strengthen comprehensive and 

integrated service delivery for 

prevention, implement strategies and 

activities that strengthen local entities, 

support the coordination, management, 

and monitoring of multi-sectoral 

implementation, foster the government’s 

capacity to provide comprehensive 

management of the HIV program, and 

implement a sustainable and qualityassured HIV diagnostic, testing, and 

health information management 

program in Namibia, Rwanda, South 

Africa, Tanzania, and Vietnam. Funding 

amounts for years 2–5 will be set at 

continuation. 

DATES: The period for these award will 

be September 30, 2024, through 

September 29, 2029. 

FOR FURTHER INFORMATION CONTACT: 

Benjamin Monroe, Center for Global 

Health, Centers for Disease Control and 

Prevention, CDC Namibia, Private Bag 

12029, Ausspannplatz, Windhoek, 

Namibia, Telephone: 404.639.1523, 

Email: ihd2@cdc.gov. 

Antyme Kayisabe, Center for Global 

Health, Centers for Disease Control and 

Prevention, US Embassy Kigali; 30KG 7 

Avenue (Kacyiru); P.O. Box 28 Kigali, 

Rwanda, Telephone: 788.382.114, 

Email: hqq9@cdc.gov. 

Rehmeth Fakroodeen, Center for 

Global Health, Centers for Disease 

Control and Prevention, 100 Totius 

Street, Groenkloof, Pretoria,0181, 

Telephone: 278.252.43786, Email: 

wzv0@cdc.gov. 

Rachael Joseph, Center for Global 

Health, Centers for Disease Control and 

Prevention, 100 Totius Street, 

Groenkloof, Pretoria,0181, Telephone: 

27 822544430, Email: vie5@cdc.gov. 

Angela Schaad, Center for Global 

Health, Centers for Disease Control and 

Prevention, 2448 Luthuli Road Dar Es 

Salaam Tanzania, Telephone: 

404.718.3639, Email: kin7@cdc.gov. 

Amy Bailey, Center for Global Health, 

Centers for Disease Control and 

Prevention, 5th/Floor Tung Shing 

Building, No 2, Ngo Quyen Street, Hoan 

Kiem District Hanoi, Vietnam, 

Telephone: 011842439352692, Email: 

fue8@cdc.gov. 

SUPPLEMENTARY INFORMATION: The(se) 

sole source award(s) will maintain HIV 

and achieve TB epidemic control and 

strengthen public health systems and 

security, implement evidence-based 

decision-making, technical leadership, 

and coordination of quality HIV 

prevention and care and treatment 

(C&T) services, strengthen systems and 

processes at multiple health system 

levels, support coordination and 

implementation of United States 

Government (USG)-funded public 

health activities, and ensure the quality 

of HIV diagnostics and testing, track the 

quality of services to persons living with 

HIV (PLHIV) on treatment, and monitor 

the cascade progression to HIV 

epidemic control in Namibia, Rwanda, 

South Africa, Tanzania, and Vietnam. 

MOHSS is in a unique position to 

conduct this work, as it is the sole 

government entity charged with the 

operation of Namibia’s public 

healthcare system. It is the only body 

authorized by law to develop and 

implement health policies in the public 

health sector, and to enforce national 

health laws in the public and private 

healthcare sectors. As the government 

ministry with exclusive authority over 

the healthcare system, it is the only 

organization in Namibia eligible to 

receive direct government-togovernment support for the HIV/AIDS 

activities proposed by CDC. 

Rwanda Biomedical Center is in a 

unique position to conduct this work, as 

it develops policies and regulations for 

medical laboratories, conducts 

specialized testing, monitors the 

performance and operation of other 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 26 / Wednesday, February 7, 2024 / Notices 8433 

laboratories in Rwanda, and establishes 

relations and collaborations with other 

national and international agencies 

carrying out similar responsibilities. No 

other agency in the public or private 

sector performs this responsibility. 

South African Medical Research 

Council is in a unique position to 

conduct this work, as it is a government 

body responsible for biomedical 

research of national importance and is 

the only agency with this direct 

governmental mandate in South Africa. 

SANAC is in a unique position to 

conduct this work, as it is mandated to 

coordinate a truly multi-sectoral 

response to the epidemics at a national 

and sub-national level. Therefore, 

SANAC is authorized to collaborate 

with government departments, the 

private health sector, other development 

partners, and non-governmental 

organizations (NGOS) to develop 

strategies to reach epidemic control. 

TACAIDS is in a unique position to 

conduct this work, as it has sole legal 

authority to provide strategic multisectorial leadership and to coordinate 

and strengthen efforts of all stakeholders 

involved in the national HIV/AIDS 

response. TACAIDS has 16 functions to 

aid in achieving their mandate. 

PO–RALG is in a unique position to 

conduct this work, as it is legally the 

only government agency that interprets 

national policies, strategies, and 

guidelines related to health and social 

welfare sector development, financing, 

and human resources; provides 

supportive supervision and mentorship 

to RAs and LGAs; and ensures 

implementation of policies and 

regulations by RAs and LGAs. PO– 

RALG has oversight and management of 

all dispensaries, health facilities, and 

regional hospitals, as well as all health 

care workers. 

VAAC is in a unique position to 

conduct this work, as it uniquely 

qualified for this funding opportunity 

because of their political mandate, 

clearly acknowledged leadership by all 

partners, and significant experience to 

continue a strong and vital coordinating 

role for HIV programs. 

Summary of the award: 

Recipient: Namibia Ministry of Health 

and Social Services (MOHSS), Rwanda 

Biomedical Center, South African 

Medical Research Council, South 

African National AIDS Council Trust 

(SANAC), Tanzania Commission for 

AIDS (TACAIDS), President’s Office— 

Regional Administration and Local 

Government (PO–RALG), and Vietnam 

Administration for HIV/AIDS Control 

(VAAC). 

Purpose of the Award: The purpose of 

these awards is to strengthen 

comprehensive and integrated service 

delivery for prevention and implement 

strategies and activities that strengthen 

local entities, support the coordination, 

management, and monitoring of multisectoral implementation, foster the 

government’s capacity to provide 

comprehensive management of the HIV 

program, and implement a sustainable 

and quality-assured HIV diagnostic, 

testing, and health information 

management program in Namibia, 

Rwanda, South Africa, Tanzania, and 

Vietnam. 

Amount of Award: For MOHSS, the 

approximate year 1 funding amount will 

be $8,000,000 in Federal Fiscal Year 

(FYY) 2024 funds, subject to the 

availability of funds. Funding amounts 

for years 2–5 will be set at continuation. 

Amount of Award: For Rwanda 

Biomedical Center, the approximate 

year 1 funding amount will be 

$4,000,000 in Federal Fiscal Year (FYY) 

2024 funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Amount of Award: For South African 

Medical Research Council, the 

approximate year 1 funding amount will 

be $(3,000,000 in Federal Fiscal Year 

(FYY) 2024 funds, subject to the 

availability of funds. Funding amounts 

for years 2–5 will be set at continuation. 

Amount of Award: For SANAC, the 

approximate year 1 funding amount will 

be $3,000,000 in Federal Fiscal Year 

(FYY) 2024 funds, subject to the 

availability of funds. Funding amounts 

for years 2–5 will be set at continuation. 

Amount of Award: For TACAIDS, the 

approximate year 1 funding amount will 

be $500,000 in Federal Fiscal Year 

(FYY) 2024 funds, subject to the 

availability of funds. Funding amounts 

for years 2–5 will be set at continuation. 

Amount of Award: For PO–RALG, the 

approximate year 1 funding amount will 

be $500,000 in Federal Fiscal Year 

(FYY) 2024 funds, subject to the 

availability of funds. 

Amount of Award: For VAAC, the 

approximate year 1 funding amount will 

be $6,000,000 in Federal Fiscal Year 

(FYY) 2024 funds, subject to the 

availability of funds. Funding amounts 

for years 2–5 will be set at continuation. 

Authority: These programs are 

authorized under Public Law 108–25 

(the United States Leadership Against 

HIV AIDS, Tuberculosis and Malaria 

Act of 2003) [22 U.S.C. 7601, et seq.] 

and Public Law 110–293 (the Tom 

Lantos and Henry J. Hyde United States 

Global Leadership Against HIV/AIDS, 

Tuberculosis, and Malaria 

Reauthorization Act of 2008), and 

Public Law 113–56 (PEPFAR 

Stewardship and Oversight Act of 2013). 

Period of Performance: The period for 

these awards will be September 30, 

2024, through September 29, 2029. 

Dated: January 24, 2024. 

Jamie Legier, 

Acting Director, Office of Grants Services, 

Acting Chief Grants Management Officer, 

Centers for Disease Control and Prevention. 

[FR Doc. 2024–02505 Filed 2–6–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Sole Source 

Cooperative Agreement To Fund the 

Pan-American Health Organization 

(PAHO) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $8,000,000, 

with an expected total funding of 

approximately $50,000,000 over a 5-year 

period, to the Pan-American Health 

Organization (PAHO). The award will 

support strengthening immunization 

systems; ensuring polio free certification 

status; maintaining measles, rubella, 

and neonatal tetanus elimination; and 

prevention of other vaccine-preventable 

diseases (VPDs) in the Americas region. 

This award builds upon and continues 

work previously supported by PAHO 

through a cooperative agreement under 

CDC–RFA–GH–1901, ‘‘Cooperative 

Agreement with the Pan American 

Health Organization: Protecting and 

Strengthening Immunization Programs 

in the Americas.’’ 

DATES: The period for this award will be 

May 1, 2024, through April 30, 2029. 

FOR FURTHER INFORMATION CONTACT: 

Mary A. Mulholland, (Global Health 

Center, Centers for Disease Control and 

Prevention, 1600 Clifton Rd. NE, 

Atlanta, GA 30333, Telephone: 404– 

553–7371, Email: mmulholland@

cdc.gov. 

SUPPLEMENTARY INFORMATION: The sole 

source award will establish a 

cooperative agreement that will build 

upon the achievements of past 

cooperative agreements with PAHO, 

while forging new collaborations to 

strengthen the Expanded Program on 

Immunization in the Americas as a 


khammond on DSKJM1Z7X2PROD with NOTICES